Richard Béliveau

发表

Sphingosine‐1‐phosphate induces the association of membrane‐type 1 matrix metalloproteinase with p130Cas in endothelial cells

D. Gingras, R. Béliveau, Denis Gingras, 2008, FEBS letters.

Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.

David Ratel, Michel Demeule, D. Gingras, 2004, Archives of biochemistry and biophysics.

Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease.

Serge Gauthier, Michel Demeule, S. Gauthier, 2003, The Biochemical journal.

The Antiangiogenic Agent Neovastat (Æ-941) Stimulates Tissue Plasminogen Activator Activity

Michel Demeule, D. Gingras, R. Béliveau, 2004, Investigational New Drugs.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Pascal Tétreault, Nicolas Beaudet, Philippe Sarret, 2014, The Journal of clinical investigation.

Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.

R. Béliveau, Richard Béliveau, Dominique Boivin, 2007, Anticancer research.

Down‐regulation of protein l‐isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin

Alain Bouthillier, Michel Demeule, R. Béliveau, 2002, Journal of neurochemistry.

High transcytosis of melanotransferrin (P97) across the blood–brain barrier

Michel Demeule, W. Jefferies, R. Béliveau, 2002, Journal of neurochemistry.

Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.

Sylvie Lamy, D. Gingras, R. Béliveau, 2006, Free radical biology & medicine.

Identification and Design of Peptides as a New Drug Delivery System for the Brain

Michel Demeule, R. Béliveau, Tran Nguyen, 2008, Journal of Pharmacology and Experimental Therapeutics.